During the past decade, Clinnova Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinnova Research" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Abivax S.A." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinnova Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clinnova Research" are "COVID-19" (2 trials), "Crohn's Disease" (2 trials), "Crohn Disease" (1 trials), "Heart Failure" (1 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Clinnova Research" in a lesser frequency.

Most popular intervention types in "Clinnova Research" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials), "Guselkumab Dose 3" (2 trials) and "ABX464" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinnova Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Clinnova Research". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinnova Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinnova Research, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".